Hypercalcemia in patients with parathyroid carcinoma or intractable PHPT
Showing 1 - 25 of 8,363
Parathyroid Carcinoma, Primary Hyperparathyroidism Trial in Osaka (KHK7580)
Completed
- Parathyroid Carcinoma
- Primary Hyperparathyroidism
-
Ōsaka, JapanOsaka City University Hospital
May 26, 2021
European Multicentric Study on Parathyroid Carcinoma
Recruiting
- Parathyroid Carcinoma
- Surgical treatment of parathyroid carcinoma
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 16, 2023
Impact of Parathyroidectomy on Renal Function
Recruiting
- Primary Hyperparathyroidism
- parathyroidectomy
-
Vandœuvre-lès-Nancy, Lorraine, FranceCHRU Nancy
Dec 2, 2022
Parathyroid Tumor Clonal Status
Active, not recruiting
- Parathyroid Tumor
- Primary Hyperparathyroidism
-
Birmingham, Alabama
- +2 more
Aug 11, 2023
Primary Hyperparathyroidism Trial in Lund (Parathyroid surgery)
Recruiting
- Primary Hyperparathyroidism
- Parathyroid surgery
-
Lund, SwedenSkåne University Hospital, Department of Surgery, Lund
Feb 28, 2022
VATS for Resection of Mediastinal Parathyroids
Completed
- Mediastinal Parathyroid Adenoma
- Hyperparathyroidism
- VATS resection of MEPA
- (no location specified)
Jan 21, 2023
Primary Hyperparathyroidism Trial in New York (Denosumab, Placebo)
Terminated
- Primary Hyperparathyroidism
- Denosumab
- Placebo
-
New York, New YorkColumbia University Medical Center
Oct 6, 2022
Glycemic Control, Type II Diabetes, Parathyroidectomy
Recruiting
- Primary Hyperparathyroidism
- Type 2 Diabetes
- Urine and Blood Test
-
Cleveland, OhioCleveland Clinic Main Campus
Feb 28, 2023
Hyperparathyroidism, Diabetes, Hypercalcemia Trial in Stockholm (parathyroidectomy)
Withdrawn
- Hyperparathyroidism
- +2 more
- parathyroidectomy
-
Stockholm, SwedenKarolinska University Hospital
Sep 6, 2020
3T MR for Secondary Hyperparathyroidism Comparison With 4DCT
Not yet recruiting
- Parathyroid Gland Disease
- Secondary Hyperparathyroidism
- (no location specified)
Sep 15, 2022
Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients
Recruiting
- Hepatocellular Carcinoma Patients
- Triphasic C.T abdomen and pelvis
-
Sohag, EgyptSohag University hospitals
Apr 26, 2023
Intractable Self-harm-What Support is Effective?
Recruiting
- Self-harm
- National specialized medical care unit for severe self-harm behaviour-Consultation model
-
Lund, Skåne, SwedenNational Highly Specialized Unit for Self-Harm Behaviours, Skåne
Oct 19, 2023
NUclear MEdicine DIagnostic and Artificial Intelligence
Not yet recruiting
- Hyperparathyroidism
- treatment program
- (no location specified)
Jul 25, 2023
Hepatocellular Carcinoma, Liver Function, Postoperative Complications Trial (Vitamin D, Placebo)
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- Vitamin D
- Placebo
- (no location specified)
Jun 4, 2023
Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)
Recruiting
- Hepatocellular Carcinoma
- Durvalumab
- +2 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023
Primary Hyperparathyroidism, Osteoporosis, Postmenopausal Trial in Philadelphia
Active, not recruiting
- Primary Hyperparathyroidism
- Osteoporosis, Postmenopausal
-
Philadelphia, PennsylvaniaPerelman Center for Advanced Medicine/ Hospital of the Universit
Sep 22, 2022
Primary Hyperparathyroidism and Gut Microbiota
Recruiting
- Hyperparathyroidism, Primary
- there will be no intervention, this is an observational study
-
Lausanne, SwitzerlandPatrizia D'amelio
Feb 28, 2022
d to Reveal Heterogeneity of Secondary Hyperparathyroidism
Not yet recruiting
- Secondary Hyperparathyroidism
- Single-cell sequencing
- (no location specified)
Nov 12, 2023
Parathyroid Adenoma, Parathyroid Tumors, Parathyroid Hyperplasia Trial in Nashville (NIRAF Detection Technology)
Active, not recruiting
- Parathyroid Adenoma
- +5 more
- NIRAF Detection Technology
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 19, 2022
Diagnostic Performance of 11C-choline PET/CT in Primary
Completed
- Primary Hyperparathyroidism
- Primary Hyperparathyroidism Due to Adenoma
- 11C-choline PET/CT
- (no location specified)
Oct 27, 2020
Natural History Study of Parathyroid Disorders
Recruiting
- Parathyroid Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Postoperative Hypoparathyroidism, Thyroid Disease, Thyroid Tumors Trial in Milwaukee (NIRAF Detection Technology)
Recruiting
- Postoperative Hypoparathyroidism
- +3 more
- NIRAF Detection Technology
-
Milwaukee, WisconsinFroedtert Hospital and Medical College of Wisconsin
Oct 11, 2022
Iatrogenic Hypocalcemia Trial in Hospitalet de Llobregat, L'Hospitalet De Llobregat (ICG angiography to show vascular map of
Recruiting
- Iatrogenic Hypocalcemia
- ICG angiography to show vascular map of parathyroid glands
-
Hospitalet de Llobregat, Barcelona, Spain
- +1 more
Jan 19, 2023
Pain, Intractable, Pain Cancer, Pain Trial in Bellaire (Resiniferatoxin, Placebo)
Recruiting
- Pain, Intractable
- +2 more
- Resiniferatoxin
- Placebo
-
La Jolla, California
- +3 more
Feb 2, 2023
PHN - Post-Herpetic Neuritis Trial in Nantong (ultrasound-guided platelet rich plasma nerve block)
Completed
- PHN - Post-Herpetic Neuritis
- ultrasound-guided platelet rich plasma nerve block
-
Nantong, Jiangsu, ChinaAffiliated Hospital of Nantong University
Sep 6, 2022